Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.
Groeneveld DJ, Sanders YV, Adelmeijer J, Mauser-Bunschoten EP, van der Bom JG, Cnossen MH, Fijnvandraat K, Laros-van Gorkom BAP, Meijer K, Lisman T, Eikenboom J, Leebeek FWG. Groeneveld DJ, et al. Among authors: fijnvandraat k. Thromb Haemost. 2018 Jan;118(1):152-160. doi: 10.1160/TH17-06-0397. Epub 2018 Jan 5. Thromb Haemost. 2018. PMID: 29304535
Health-related quality of life among adult patients with moderate and severe von Willebrand disease.
de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, Leebeek FW; Win Study Group. de Wee EM, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2010 Jul;8(7):1492-9. doi: 10.1111/j.1538-7836.2010.03864.x. Epub 2010 Mar 23. J Thromb Haemost. 2010. PMID: 20345712 Free article.
Impact of von Willebrand disease on health-related quality of life in a pediatric population.
de Wee EM, Fijnvandraat K, de Goede-Bolder A, Mauser-Bunschoten EP, Eikenboom JC, Brons PP, Smiers FJ, Tamminga R, Oostenbrink R, Raat H, van der Bom JG, Leebeek FW; WiN Study Group. de Wee EM, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2011 Mar;9(3):502-9. doi: 10.1111/j.1538-7836.2010.04175.x. J Thromb Haemost. 2011. PMID: 21166992 Free article.
Surgery and inhibitor development in hemophilia A: a systematic review.
Eckhardt CL, van der Bom JG, van der Naald M, Peters M, Kamphuisen PW, Fijnvandraat K. Eckhardt CL, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2011 Oct;9(10):1948-58. doi: 10.1111/j.1538-7836.2011.04467.x. J Thromb Haemost. 2011. PMID: 21838755 Free article. Review.
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
De Wee EM, Klaij K, Eikenboom HC, Van Der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Mauser-Bunschoten EP, Meijer K, Goverde G, Van Der Linden PW, Rijken DC, Leebeek FW; WiN Study Group. De Wee EM, et al. Among authors: fijnvandraat k. Haemophilia. 2012 May;18(3):444-51. doi: 10.1111/j.1365-2516.2011.02645.x. Epub 2011 Sep 12. Haemophilia. 2012. PMID: 21910790
Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease.
De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW; WiN study group. De Wee EM, et al. Among authors: fijnvandraat k. Thromb Haemost. 2011 Nov;106(5):885-92. doi: 10.1160/TH11-03-0180. Epub 2011 Sep 22. Thromb Haemost. 2011. PMID: 21947221
235 results